Apparent diffusion coefficient for discriminating metastatic from non-metastatic lymph nodes in primary rectal cancer.

OBJECTIVE To investigate whether the apparent diffusion coefficient (ADC) could be used to discriminate metastatic from non-metastatic lymph nodes (LNs) in patients with primary rectal cancer. METHODS This study investigated 34 patients (male: 12, female: 22, mean: 62.7, range: 37-82) who underwent 1.5-T MRI with diffusion-weighted imaging (DWI) and subsequent surgical resection. A blinded radiologist measured the ADC value in each regional LN after referring to the T2-weighted images and DWI. The t-test was used to compare the mean ADC values of the metastatic and non-metastatic LNs. A ROC analysis was performed to calculate the diagnostic performance and obtain the optimal cut-off. The histopathological results were used as the reference standard. RESULTS 114 LNs (46 metastatic and 68 non-metastatic) were matched and analyzed. The mean ADC of the metastatic LNs was significantly lower than that of the non-metastatic LNs (0.9 ± 0.15 × 10(-3) mm(2)/s; 1.1 ± 0.22 × 10(-3) mm(2)/s, P<0.0001). The area under the ROC curve was 0.734 (95% confidence interval, 0.644-0.812). When an ADC value of 1.0 × 10(-3) mm(2)/s was used as the cut-off, a maximum accuracy of 72% was calculated (sensitivity, 78%; specificity, 67%). CONCLUSIONS Although ADC could be used to discriminate metastatic from non-metastatic LNs, the diagnostic accuracy is approximately 70%.

[1]  A. Kessels,et al.  Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery , 2001, The Lancet.

[2]  Myeong-Jin Kim,et al.  High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? , 2004, European journal of radiology.

[3]  J. V. van Engelshoven,et al.  USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. , 2008, Radiology.

[4]  T. Leiner,et al.  Accuracy of Gadofosveset-enhanced MRI for Nodal Staging and Restaging in Rectal Cancer , 2011, Annals of surgery.

[5]  D. Collins,et al.  TECHNICAL ARTICLE: Fusion of high b‐value diffusion‐weighted and T2‐weighted MR images improves identification of lymph nodes in the pelvis , 2010, Journal of medical imaging and radiation oncology.

[6]  A. A. Abdel Razek,et al.  Role of diffusion-weighted MR imaging in cervical lymphadenopathy , 2006, European Radiology.

[7]  Patrick M M Bossuyt,et al.  Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. , 2004, Radiology.

[8]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[9]  C. Compton,et al.  Colon and Rectum , 2012 .

[10]  S. Andreola,et al.  Manual dissection of adenocarcinoma of the lower third of the rectum specimens for detection of lymph node metastases smaller than 5 mm , 1996, Cancer.

[11]  G. Beets,et al.  Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer—a per lesion validation study , 2010, European Radiology.

[12]  Laurence Collette,et al.  Chemotherapy with preoperative radiotherapy in rectal cancer. , 2006, The New England journal of medicine.

[13]  David J Collins,et al.  Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapy , 2008, Nature Clinical Practice Oncology.

[14]  Geerard L Beets,et al.  Rectal cancer: review with emphasis on MR imaging. , 2004, Radiology.

[15]  S. Galimberti,et al.  ADC maps in the prediction of pelvic lymph nodal metastatic regions in endometrial cancer , 2012, European Radiology.

[16]  C. Roy,et al.  Value of diffusion-weighted imaging to detect small malignant pelvic lymph nodes at 3 T , 2010, European Radiology.

[17]  Namkug Kim,et al.  Relative apparent diffusion coefficient: Determination of reference site and validation of benefit for detecting metastatic lymph nodes in uterine cervical cancer , 2009, Journal of magnetic resonance imaging : JMRI.

[18]  Hye Rim Cho,et al.  Imaging and quantification of metastatic melanoma cells in lymph nodes with a ferritin MR reporter in living mice , 2012, NMR in biomedicine.

[19]  Makoto Sato,et al.  Diffusion-weighted imaging in the detection of lymph node metastasis in colorectal cancer. , 2009, The Tohoku journal of experimental medicine.

[20]  T. Yoshioka,et al.  The size of regional lymph nodes does not correlate with the presence or absence of metastasis in lymph nodes in rectal cancer , 1993, Journal of surgical oncology.

[21]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[22]  C. Kane,et al.  A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. , 2012, Radiology.

[23]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[24]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[25]  D. Collins,et al.  Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.

[26]  Jeong Min Lee,et al.  Evaluation of lymph node metastases: Comparison of gadofluorine M‐enhanced MRI and diffusion‐weighted MRI in a rabbit VX2 rectal cancer model , 2012, Journal of magnetic resonance imaging : JMRI.

[27]  Namkug Kim,et al.  Feasibility of diffusion‐weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: Early experience , 2008, Journal of magnetic resonance imaging : JMRI.

[28]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[29]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[30]  R G Newcombe,et al.  Preoperative assessment of prognostic factors in rectal cancer using high‐resolution magnetic resonance imaging , 2003, The British journal of surgery.

[31]  A. Razek,et al.  Role of Diffusion-Weighted Echo-Planar MR Imaging in Differentiation of Residual or Recurrent Head and Neck Tumors and Posttreatment Changes , 2007, American Journal of Neuroradiology.

[32]  J. V. van Engelshoven,et al.  Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? , 2009, Radiology.